摘要
AIM To clarify the prognostic significance of preoperative albumin-to-alkaline phosphatase ratio(AAPR) in cholangiocarcinoma(CCA) subjects receiving surgery.METHODS In this retrospective study, we included 303 CCA patients receiving surgery without preoperative therapy between 2002 and 2014. Clinicopathological characteristics(including AAPR) were analyzed to determine predictors of postoperative overall survival and recurrence-free survival(RFS). In addition,univariate and multivariate Cox proportional hazards models were conducted,followed by application of time-dependent receiver operating curves to identify the optimal cut-off.RESULTS Univariate and multivariate analyses revealed both decreased overall survival[hazard ratio(HR): 2.88, 95%CI: 1.19-5.78] and recurrence-free survival(HR: 2.31,95%CI: 1.40–3.29) in patients with AAPR < 0.41 compared to those with AAPR ≥0.41. The optimal cut-off of AAPR was 0.41. Of the 303 subjects, 253(83.5%) had an AAPR over 0.41. The overall 1-, 3- and 5-year survival rates were 70.2%, 38.0% and 16.5%, respectively in the low(< 0.41) AAPR group, which were significantly lower than those in the high(≥ 0.41) AAPR group(81.7%, 53.9%, and 33.4%,respectively)(P < 0.0001). Large tumor size, multiple tumors, and advanced clinical stage were also identified as significant predictors of poor prognosis.CONCLUSION Our outcomes showed that AAPR was a potential valuable prognostic indicator in CCA patients undergoing surgery, which should be further confirmed by prospective studies. Moreover, it is necessary to investigate the mechanisms concerning the correlation of low AAPR with poor post-operative survival in CCA patients.
AIM To clarify the prognostic significance of preoperative albumin-to-alkaline phosphatase ratio(AAPR) in cholangiocarcinoma(CCA) subjects receiving surgery.METHODS In this retrospective study, we included 303 CCA patients receiving surgery without preoperative therapy between 2002 and 2014. Clinicopathological characteristics(including AAPR) were analyzed to determine predictors of postoperative overall survival and recurrence-free survival(RFS). In addition,univariate and multivariate Cox proportional hazards models were conducted,followed by application of time-dependent receiver operating curves to identify the optimal cut-off.RESULTS Univariate and multivariate analyses revealed both decreased overall survival[hazard ratio(HR): 2.88, 95%CI: 1.19-5.78] and recurrence-free survival(HR: 2.31,95%CI: 1.40–3.29) in patients with AAPR < 0.41 compared to those with AAPR ≥0.41. The optimal cut-off of AAPR was 0.41. Of the 303 subjects, 253(83.5%) had an AAPR over 0.41. The overall 1-, 3- and 5-year survival rates were 70.2%, 38.0% and 16.5%, respectively in the low(< 0.41) AAPR group, which were significantly lower than those in the high(≥ 0.41) AAPR group(81.7%, 53.9%, and 33.4%,respectively)(P < 0.0001). Large tumor size, multiple tumors, and advanced clinical stage were also identified as significant predictors of poor prognosis.CONCLUSION Our outcomes showed that AAPR was a potential valuable prognostic indicator in CCA patients undergoing surgery, which should be further confirmed by prospective studies. Moreover, it is necessary to investigate the mechanisms concerning the correlation of low AAPR with poor post-operative survival in CCA patients.
引文
1 Olnes MJ,Erlich R.A review and update on cholangiocarcinoma.Oncology 2004;66:167-179[PMID:15218306 DOI:10.1159/000077991]
2 Vijgen S,Terris B,Rubbia-Brandt L.Pathology of intrahepatic cholangiocarcinoma.Hepatobiliary Surg Nutr 2017;6:22-34[PMID:28261592 DOI:10.21037/hbsn.2016.11.04]
3 Vauthey JN,Blumgart LH.Recent advances in the management of cholangiocarcinomas.Semin Liver Dis 1994;14:109-114[PMID:8047893 DOI:10.1055/s-2007-1007302]
4 Shaib Y,El-Serag HB.The epidemiology of cholangiocarcinoma.Semin Liver Dis 2004;24:115-125[PMID:15192785 DOI:10.1055/s-2004-828889]
5 Taylor-Robinson SD,Toledano MB,Arora S,Keegan TJ,Hargreaves S,Beck A,Khan SA,Elliott P,Thomas HC.Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.Gut 2001;48:816-820[PMID:11358902 DOI:10.1136/gut.48.6.816]
6 Shaib YH,Davila JA,McGlynn K,El-Serag HB.Rising incidence of intrahepatic cholangiocarcinoma in the United States:a true increase?J Hepatol 2004;40:472-477[PMID:15123362 DOI:10.1016/j.jhep.2003.11.030]
7 Lepage C,Cottet V,Chauvenet M,Phelip JM,Bedenne L,Faivre J,Bouvier AM.Trends in the incidence and management of biliary tract cancer:a French population-based study.J Hepatol2011;54:306-310[PMID:21056501 DOI:10.1016/j.jhep.2010.06.039]
8 Pawlik TM.Intrahepatic cholangiocarcinoma:from diagnosis to treatment.Hepatobiliary Surg Nutr 2017;6:1[PMID:28261589 DOI:10.21037/hbsn.2017.01.04]
9 Saito N,Shirai Y,Horiuchi T,Sugano H,Shiba H,Sakamoto T,Uwagawa T,Yanaga K.Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Cholangiocarcinoma.Anticancer Res 2018;38:987-992[PMID:29374731 DOI:10.21873/anticanres.12313]
10 Lin Q,Lin ZH,Chen J,Lin JX,Li X,Jiang JR,Ma XK,Wu DH,Chen ZH,Dong M,Wei L,Wang TT,Ruan DY,Lin ZX,Wen JY,Wu XY,Huang MS.Prognostic significance of preoperative albumin-to-globulin ratio in patients with cholangiocarcinoma.Curr Res Transl Med 2017;65:83-87[PMID:28684265 DOI:10.1016/j.retram.2017.06.002]
11 Jing CY,Fu YP,Shen HJ,Zheng SS,Lin JJ,Yi Y,Huang JL,Xu X,Zhang J,Zhou J,Fan J,Ren ZG,Qiu SJ,Zhang BH.Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection.Oncotarget 2017;8:13293-13303[PMID:28076328 DOI:10.18632/oncotarget.14530]
12 Tan DW,Fu Y,Su Q,Guan MJ,Kong P,Wang SQ,Wang HL.Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma:A Metaanalysis.Sci Rep 2016;6:33789[PMID:27694951 DOI:10.1038/srep33789]
13 Cai X,Chen Z,Chen J,Ma X,Bai M,Wang T,Chen X,Wu D,Wei L,Li X,Lin Q,Wen J,Ruan D,Lin Z,Dong M,Wu X.Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.J Cancer 2018;9:189-197[PMID:29290785 DOI:10.7150/jca.21799]
14 Tanriverdi O.A discussion of serum albumin level in advanced-stage hepatocellular carcinoma:a medical oncologist's perspective.Med Oncol 2014;31:282[PMID:25316265 DOI:10.1007/s12032-014-0282-3]
15 Arroyo V,García-Martinez R,Salvatella X.Human serum albumin,systemic inflammation,and cirrhosis.J Hepatol 2014;61:396-407[PMID:24751830 DOI:10.1016/j.jhep.2014.04.012]
16 Gion T,Taketomi A,Shimada M,Shirabe K,Hasegawa H,Takenaka K,Sugimachi K.Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma.Hepatology 1998;28:1663-1668[PMID:9828232 DOI:10.1002/hep.510280628]
17 Heys SD,Walker LG,Deehan DJ,Eremin OE.Serum albumin:a prognostic indicator in patients with colorectal cancer.J R Coll Surg Edinb 1998;43:163-168[PMID:9654876]
18 Chi KN,Kheoh T,Ryan CJ,Molina A,Bellmunt J,Vogelzang NJ,Rathkopf DE,Fizazi K,Kantoff PW,Li J,Azad AA,Eigl BJ,Heng DY,Joshua AM,de Bono JS,Scher HI.A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.Ann Oncol 2016;27:454-460[PMID:26685010 DOI:10.1093/annonc/mdv594]
19 Kaplan MM.Alkaline phosphatase.Gastroenterology 1972;62:452-468[PMID:4551808]
20 Giljaca V,Stimac D,Gluud C.Are levels of alkaline phosphatases and bilirubin surrogate markers of outcomes of patients with primary biliary cirrhosis?Gastroenterology 2015;148:860[PMID:25726742 DOI:10.1053/j.gastro.2014.11.050]
21 Mayne PD,Thakrar S,Rosalki SB,Foo AY,Parbhoo S.Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity.J Clin Pathol 1987;40:398-403[PMID:3584482 DOI:10.1136/jcp.40.4.398]
22 Al Mamari S,Djordjevic J,Halliday JS,Chapman RW.Improvement of serum alkaline phosphatase to<1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.J Hepatol 2013;58:329-334[PMID:23085647 DOI:10.1016/j.jhep.2012.10.013]
23 Yu MC,Chan KM,Lee CF,Lee YS,Eldeen FZ,Chou HS,Lee WC,Chen MF.Alkaline phosphatase:does it have a role in predicting hepatocellular carcinoma recurrence?J Gastrointest Surg 2011;15:1440-1449[PMID:21541770 DOI:10.1007/s11605-011-1537-3]
24 Leung TW,Tang AM,Zee B,Lau WY,Lai PB,Leung KL,Lau JT,Yu SC,Johnson PJ.Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system,the Okuda staging system,and the Cancer of the Liver Italian Program staging system:a study based on 926 patients.Cancer 2002;94:1760-1769[PMID:11920539 DOI:10.1002/cncr.10384]
25 Chan AW,Chan SL,Mo FK,Wong GL,Wong VW,Cheung YS,Chan HL,Yeo W,Lai PB,To KF.Albumin-to-alkaline phosphatase ratio:a novel prognostic index for hepatocellular carcinoma.Dis Markers 2015;2015:564057[PMID:25737613 DOI:10.1155/2015/564057]
